Back to results
US 8,283,371 B2Granted
Compounds
AssigneeNovacta Biosystems Limited
InventorSjoerd Nicolaas Wadman
Life of this patent
Estimating the term…
Abstract
The present invention pertains generally to certain compounds of the deoxyactagardine A and B type. Such compounds are suitable for use in the treatment of microbial infections, for example Clostridium infection, such as C. perfringens, C. difficile, C. tetani, and/or C. botulinum, in particular C. difficile, especially infection of the colon and/or lower intestines and diarrhea associated with the microbial infection.
Claims4
A compound deoxyactagardine B (7-amino-1-heptylamide monocarboxamide), and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.